Sealantium Medical Belgium

Sealantium Medical Belgium

Foundation date

August 20, 2024

Sector

#Biotechnology - other

Sealantium Medical is a biosurgery company focused on the development of proprietary next generation tissue sealants and hemostatic agents for patients undergoing surgery.

Successful preclinical data has demonstrated the efficacy and usability of the sFilm-FS™. Promising early phase-II clinical results show safety and a faster performance in controlling bleeding during surgery than the market-leading product.

sFilm-FS™ will be the first, innovative hemostatic and sealing patch to address the more than $1 billion surgical sealant market in almost a decade.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    22 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    Wednesday November 20th 2024

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024